Press release
Pyrimethamine Market 2023 Driving Factors Forecast Research 2029
Pyrimethamine Market
Get Free Sample link @ https://www.omrglobal.com/request-sample/pyrimethamine-market
Pyrimethamine is a folic acid antagonist that is used as an antimalarial or in combination with a sulphonamide to treat toxoplasmosis. Pyrimethamine prevents the production of purines and pyrimidines, which are required for DNA synthesis and cell proliferation, by inhibiting plasmodia dihydrofolate reductase. Nuclear division failure occurs during schizont development in erythrocytes and the liver as a result of this process. It's often utilized as a supplement in the treatment of uncomplicated P. falciparum malaria that's resistant to chloroquine.
full report of Pyrimethamine Market available @ https://www.omrglobal.com/industry-reports/pyrimethamine-market
• Market Coverage
• Market number available for - 2023-2029
• Base year- 2022
• Forecast period- 2023-2029
• Segment Covered- By Source, By Product Type, By Applications
• Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill
• Inc., and others
Pyrimethamine Market Report
By Type
• Tablets
• Capsules
• Injectables
By Drug
• Daraprim
• Fansidar
By End-User vertical
• Hospitals and Clinics
• Laboratories
• Others
By Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/pyrimethamine-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pyrimethamine Market 2023 Driving Factors Forecast Research 2029 here
News-ID: 3273534 • Views: …
More Releases from orion market research
Automotive Seat Market Size Future Scope, Demands and Projected Industry Growths …
The global automotive seat market was valued at approximately USD 80.5 billion in 2023 and is projected to reach around USD 135.1 billion by 2033, reflecting an estimated compound annual growth rate (CAGR) of about 5.2% from 2024 to 2033.
Automotive Seat Market Overview
The automotive seat market is experiencing robust growth driven by rising consumer expectations for comfort, safety, and personalization in vehicle interiors. Increasing demand for advanced seating features-such as…
Sunglasses Market Size Future Scope, Demands and Projected Industry Growths to 2 …
The global sunglasses market was valued at approximately USD 24.4 billion in 2023 and is projected to reach around USD 40.9 billion by 2033, reflecting an estimated compound annual growth rate (CAGR) of about 5.22% from 2024 to 2033.
Sunglasses Market Overview
The sunglasses market is experiencing steady growth, driven by increasing awareness of eye health and the harmful effects of ultraviolet (UV) radiation. Consumers are increasingly seeking eyewear that offers both…
Anti-Venom Market Size Analysis, Competitive Insights, Leading Players and Growt …
The global anti‐venom market was valued at approximately USD 359.9 million in 2023 and is projected to reach around USD 691.0 million by 2033, translating to an estimated compound annual growth rate (CAGR) of 6.7% between 2024 and 2033.
Anti-Venom Market Overview
The anti venom market plays a critical role in combating envenomation from venomous species like snakes, spiders, and scorpions by providing life-saving neutralizing treatments. Growth in this sector is driven…
Antipyretic Drug Market Size Future Scope, Demands and Projected Industry Growth …
The global antipyretic analgesics market was valued at approximately USD 2.82 billion in 2023 and is projected to reach around USD 3.03 billion by 2033, corresponding to a compound annual growth rate (CAGR) of about 1.2% from 2024 to 2033.
Antipyretic Drug Market Overview
The antipyretic analgesics market plays a vital role in healthcare, offering essential tools for managing fever, pain, and inflammation through widely used OTC and prescription medications. Consumer preference…
More Releases for Pyrimethamine
Unraveling the Global Pyrimethamine Market: Trends, Impacts, and Future Insights
𝐈𝐧𝐭𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧:
Pyrimethamine, a vital antiparasitic medication, has been a cornerstone in the treatment and prevention of malaria and toxoplasmosis. This blog delves into the intricate dynamics of the global pyrimethamine market, examining its size, share, and the transformative impacts of the COVID-19 pandemic, while also projecting trends up to 2031.
𝐄𝐱𝐩𝐥𝐨𝐫𝐢𝐧𝐠 𝐏𝐲𝐫𝐢𝐦𝐞𝐭𝐡𝐚𝐦𝐢𝐧𝐞:
Pyrimethamine, a dihydrofolate reductase inhibitor, exerts its antiparasitic effects by disrupting the folate metabolism of protozoan parasites such as Plasmodium spp.…
Pyrimethamine Market Outlook 2029: Presents Market Insights & Depth Analysis
The global pyrimethamine market is expected to grow at a significant CAGR during the forecast period. Pyrimethamine is a protozoan infection treatment drug. It's frequently used as an antimalarial medication (for both treatment and prevention of malaria) as well as to treat Toxoplasma gondii infections, especially when coupled with the sulfonamide antibiotic sulfadiazine in HIV-positive patients. Owing to its resistance to several plasmodium species, pyrimethamine is usually combined with sulfonamide…
Why the Market for Pyrimethamine May Be Poised to Take Off
Market Research, INC. has recently published a report on Pyrimethamine market which is an essential tool for businesses to gather critical insights about their target markets, competitors, and industry trends. With the increasing complexity of the global business environment, companies need accurate and up-to-date information to make informed decisions and stay ahead of the competition. That's why we are excited to announce the release of our latest market research report,…
Pyrimethamine Market Trends, Business Growth and Major Driving Factors 2028
Pyrimethamine is a medication used for protozoan infections. It is commonly used as an antimalarial drug (for both treatment and prevention of malaria), and to treat Toxoplasma gondii infections, particularly when combined with the sulfonamide antibiotic sulfadiazine when treating HIV-positive individuals. Pyrimethamine is typically given with a sulfonamide and folinic acid due to its resistance against many Plasmodium species. Pyrimethamine has also been found to limit the expression of the…
Pyrimethamine Treatment Market Research Report- Forecast to 2023
Pyrimethamine is a medication used for protozoan infections. It is commonly used as an antimalarial drug (for both treatment and prevention of malaria), and to treat Toxoplasma gondii infections, particularly when combined with the sulfonamide antibiotic sulfadiazine when treating HIV-positive individuals. Pyrimethamine is typically given with a sulfonamide and folinic acid due to its resistance against many Plasmodium species. Pyrimethamine has also been found to limit the expression of the…
Pyrimethamine Treatment Market: Technologies, Markets and Players
Some of the major players in pyrimethamine treatment market include Turing Pharmaceuticals, Impax Laboratories, Inc., Pfizer, Inc. GlaxoSmithKline plc, and others.
Pyrimethamine is a medication used for protozoan infections. It is commonly used as an antimalarial drug (for both treatment and prevention of malaria), and to treat Toxoplasma gondii infections, particularly when combined with the sulfonamide antibiotic sulfadiazine when treating HIV-positive individuals. Pyrimethamine is typically given with a sulfonamide and folinic…
